Global Endowment Management LP Decreases Holdings in Oscar Health, Inc. (NYSE:OSCR)

Key Points

• Global Endowment Management LP has reduced its stake in Oscar Health, Inc. by 49.5% in Q1, now holding 19,429 shares valued at approximately $255,000.
• Multiple hedge funds have varied their positions in Oscar Health, with CWM LLC increasing their stake by 50.7% in the same quarter, while Barclays set a target price reduction from $17.00 to $11.00.
• Oscar Health reported a 29.0% annual increase in revenue, reaching $2.86 billion but posted a negative earnings per share of ($0.89) for the quarter.

Global Endowment Management LP cut its stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 49.5% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 19,429 shares of the company's stock after selling 19,017 shares during the period. Global Endowment Management LP's holdings in Oscar Health were worth $255,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the stock. Tempus Wealth Planning LLC raised its stake in Oscar Health by 6.7% during the 1st quarter. Tempus Wealth Planning LLC now owns 14,392 shares of the company's stock valued at $189,000 after buying an additional 906 shares during the last quarter. Xponance Inc. raised its stake in Oscar Health by 7.1% during the 1st quarter. Xponance Inc. now owns 15,423 shares of the company's stock valued at $202,000 after buying an additional 1,029 shares during the last quarter. CWM LLC raised its stake in Oscar Health by 50.7% during the 1st quarter. CWM LLC now owns 3,204 shares of the company's stock valued at $42,000 after buying an additional 1,078 shares during the last quarter. Summit Investment Advisors Inc. raised its stake in Oscar Health by 5.8% during the 4th quarter. Summit Investment Advisors Inc. now owns 20,838 shares of the company's stock valued at $280,000 after buying an additional 1,141 shares during the last quarter. Finally, Oppenheimer & Co. Inc. raised its stake in Oscar Health by 4.6% during the 1st quarter. Oppenheimer & Co. Inc. now owns 28,362 shares of the company's stock valued at $372,000 after buying an additional 1,250 shares during the last quarter. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Trading Up 6.5%

Shares of OSCR stock opened at $15.63 on Friday. Oscar Health, Inc. has a 52-week low of $11.20 and a 52-week high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.86 and a current ratio of 0.86. The firm has a market capitalization of $3.98 billion, a PE ratio of -19.30 and a beta of 1.86. The stock has a fifty day simple moving average of $15.94 and a two-hundred day simple moving average of $14.82.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.90) by $0.01. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%. The business had revenue of $2.86 billion during the quarter, compared to analyst estimates of $2.88 billion. During the same quarter in the prior year, the business posted $0.20 EPS. Oscar Health's revenue for the quarter was up 29.0% compared to the same quarter last year. On average, analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on OSCR shares. Barclays decreased their target price on shares of Oscar Health from $17.00 to $11.00 and set an "underweight" rating for the company in a research note on Wednesday, July 23rd. Raymond James Financial cut Oscar Health from an "outperform" rating to a "market perform" rating in a report on Tuesday, June 24th. Wall Street Zen lowered Oscar Health from a "hold" rating to a "sell" rating in a report on Saturday, August 9th. UBS Group reissued a "sell" rating and set a $11.00 price target (down previously from $15.00) on shares of Oscar Health in a report on Tuesday, July 15th. Finally, Wells Fargo & Company lowered Oscar Health from an "equal weight" rating to an "underweight" rating and cut their price target for the company from $16.00 to $10.00 in a report on Friday, July 11th. Six investment analysts have rated the stock with a sell rating and four have issued a hold rating to the stock. According to data from MarketBeat, Oscar Health currently has a consensus rating of "Reduce" and a consensus target price of $12.07.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.